Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

Cokmert, Suna; Demir, LÜTFİYE; Can, Alper; Akyol, Murat; Bayoglu, Ibrahim; Dirican, Ahmet; Kucukzeybek, Yuksel; Erten, Cigdem; Tarhan, Mustafa

Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

Copy For Citation

Cokmert S., Demir L., Can A., Akyol M., Bayoglu I. V., Dirican A., ...More

JOURNAL OF BUON, vol.19, no.1, pp.75-82, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 19 Issue: 1
Publication Date: 2014
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.75-82
Eskisehir Osmangazi University Affiliated: Yes

Abstract

Purpose: Erythrocyte mean corpuscular volume (MCV) increase has been described in patients treated with capaecitabine. In this study, we sought to evaluate the potential association of the erythrocyte MCV increase with tumor response and survival in patients with metastatic colorectal cancer (mCRC) treated with capecitabine.